A closing dressing bolster and assembly for use with a system for treating a linear wound on a patient includes a bolster body formed from a flexible closing bolster material having closing members that are operable to develop an inward closing force when the closing dressing bolster is placed under reduced pressure. In one aspect, when the closing dressing bolster is under reduced pressure, the system, dressing, or assembly develops an inward force realized at the linear wound and a compression force. A wicking-material holder and wicking material may be used as well. The member components may all be see-through to allow visual inspection of the wound without requiring removal of the dressing.

A method of promoting hemostasis in the mouth or oral cavity utilizes a non-absorbent, low surface energy and highly conformable non-disruptive hemostasis material. Traditional wound packing material is highly absorbent and has large open surfaces that allow clot forming materials, such as the platelet plug to adhere to the packing material and whereupon removal, the clot is disrupted. A non-disruptive highly conformable hemostasis material does not have large open pores and therefore does not adhere to forming clots. A non-disruptive hemostasis material may consist of expanded polytetrafluoroethylene that has a pore size of no more than about 10 microns. A non-disruptive hemostasis material may comprise a thin film of material over a portion of the outside surface that is non-absorbent and thin to allow for conforming into an oral cavity, such as from a tooth extraction. A thin film may cover porous material, such as a foam, that may be elastomeric.

A fluorescent oxygen sensing ink includes at least one organic solvent, at least one polymer binder disposed in the organic solvent, and an oxygen-sensitive fluorescent dye disposed in the organic solvent. The oxygen-sensitive fluorescent dye and the at least one polymer can interact to form a moisture-resistant film. The fluorescent oxygen sensing ink can be incorporated into an oxygen sensing wound dressing.

The invention relates to a unit for hemostasis. The unit is configured to be directly applied to a bleeding wound and comprises an envelope enclosing an inner space as well as an effective amount of a hemostatic material disposed within the inner space. Furthermore, the invention relates to an arrangement of two or more such units for hemostasis, the units being coupled to each other. Moreover, the invention relates to a method for producing an arrangement of units for hemostasis. In accordance with the method, an effective amount of a hemostatic material is disposed within an interior region of a starting material, and neck regions are formed on both sides of the charge so as to form an envelope enclosing the charge.

Wounds dressings, systems, and methods are presented that involve using a patient's body heat to enhance liquid removal from the wound dressing through a high-moisture-vapor-transmission-rate drape. Additional heat sources or devices, such as nano-antennas or electrical heating elements, may be added or used separately to enhance the removal liquid from the wound dressing. Other dressings, systems, and methods are presented herein.

A wound healing device and method that greatly reduces the risk of infection of an incision or wound by removing fluid from the subcutaneous skin layers. The wound healing device includes a first portion that is positioned external of, and on top of, the wound. At least one strip, cord, finger, member is in fluid communication at one end with the first portion while the second free end of the at least one strip, cord, finger, member is pushed down into the wound, in between the sutures or staples of a closed incision. Both the first portion and the at least one strip comprise fluid absorbable material for absorbing the wound fluid. The device remains in place for approximately 1-3 days after which it is removed. Upon removal, natural temporary “type of fistulae” are formed in the subcutaneous skin layers to continue draining wound fluids upward for another 1-2 days.

The present disclosure provides a magnetic dressing and a preparation method and use thereof, belonging to the technical field of pharmaceutical preparations. The magnetic dressing includes a magnetic layer, a drug-loading layer, and a protective layer that are stacked in sequence, where the magnetic layer includes polyvinyl alcohol, gluten, and iron particles. In the present disclosure, a swallowed magnetic dressing is controlled by an external magnetic field, and the magnetic dressing is moved to a pathological position by changing a direction of the external magnetic field; after the external magnetic field is removed, the magnetic dressing changes from a ring to a sheet, thereby completing attachment of an entire lesion surface to complete treatment by autonomous drug release.

A composite material is described, which is of particular use in wound treatment, and to a method for producing said composite material is also described. The composite material has a first foam layer having a first hydrophilic polyurethane foam material, and, in immediate contact therewith, a second foam layer having a second hydrophilic polyurethane foam material, which second hydrophilic foam material is different from the first hydrophilic foam material.

A vented wound dressing barrier includes one or more membrane layers with a plurality of vents. The vents are cut along a perimeter of the vents through the one or more membrane layers. Each vent having a connection portion uncut relative to the one or more membrane layers thereby forming a hinge configured to allow the vents to open for drainage when exposed to fluid underlying the vented wound dressing barrier. The plurality of vents is each cut along the perimeter without removal of any of the membrane layer. The one or more membrane layers with the plurality of vents has a surface for covering a wound, the surface area in the absence of a fluid pressing on the vents having no openings or voids which reduce the surface area of a vented wound dressing barrier area covering a wound.

A securement device configured to secure an external portion of a medical device to the skin surface of a patient after an internal portion of the device has been placed in the patient is disclosed. The securement device includes a retainer that is employed to securely retain the external portion of the medical device in place. The retainer is attached to a base, such as an adhesive pad that adhesively attaches to the skin surface. In one embodiment, therefore, a retainer comprises a body defining a channel configured to receive therein a portion of the medical device, and at least one foot extending from the body that is configured to stabilize the retainer with respect to a skin surface. The retainer body further includes a nose that is configured to deflect a portion of the external portion of the medical device toward the skin insertion site.